These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23404638)

  • 1. Simultaneous double hemodialysis for the control of refractory hyperammonemia.
    Brucculeri M; Gabbard W; Masson J; Jooma N
    Int J Artif Organs; 2013 Feb; 36(2):135-8. PubMed ID: 23404638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary plasma cell leukemia (IgD-lambda) with hyperammonemia].
    Minauchi K; Fujie T; Matsubara N; Kasahara H; Ogura Y; Tamura M; Yamane Y; Tanaka M; Taneichi K
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):139-41. PubMed ID: 14968586
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience.
    Chen C; Bain KB; Iuppa JA; Yusen RD; Byers DE; Patterson GA; Trulock EP; Hachem RR; Witt CA
    Transplantation; 2016 Mar; 100(3):678-84. PubMed ID: 26335916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous hemodialysis therapy for an extremely low-birthweight infant with hyperammonemia.
    Kaneko M; Ogasawara K; Go H; Imamura T; Momoi N; Hosoya M
    Pediatr Int; 2013 Oct; 55(5):656-8. PubMed ID: 24134757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Achievement of hemodialysis discontinuation with lenalidomide and dexamethasone therapy in a refractory BJP-type multiple myeloma patient].
    Uchida T; Inoue M; Hua J; Hagihara M
    Rinsho Ketsueki; 2016 May; 57(5):613-7. PubMed ID: 27263787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemic encephalopathy in multiple myeloma.
    Jones FM; Bokhari SW
    Ann Hematol; 2014 Aug; 93(8):1431-2. PubMed ID: 24292538
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators.
    Picca S; Dionisi-Vici C; Abeni D; Pastore A; Rizzo C; Orzalesi M; Sabetta G; Rizzoni G; Bartuli A
    Pediatr Nephrol; 2001 Nov; 16(11):862-7. PubMed ID: 11685590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of hyperammonemia complication of high-protein parenteral nutrition.
    Pillai U; Kahlon R; Sondheimer J; Cadnapaphorncai P; Bhat Z
    JPEN J Parenter Enteral Nutr; 2013 Jan; 37(1):134-7. PubMed ID: 22610979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
    Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Venovenous Hemodialysis Via Extracorporeal Membrane Oxygenation Pump for Treatment of Hyperammonemia Secondary to Propionic Acidemia in Monochorionic Diamniotic Twin Boys.
    Wen JX; Feldenberg LR; Abraham E; Sadiq F; Christensen KM; Braddock SR
    J Pediatr; 2016 Aug; 175():231-2. PubMed ID: 27283461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperammoniemia due to portal-systemic shunt developed after initiation of hemodialysis in a chronic renal failure patient].
    Kondo M; Yamamoto H; Ikeda M; Horiguchi M; Utsunomiya Y; Hosoya T
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1637-8. PubMed ID: 15384695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myeloma].
    Esaki M; Ishii K; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Satake A; Ito T; Nomura S
    Rinsho Ketsueki; 2016 Jul; 57(7):854-8. PubMed ID: 27498728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of 35 critically ill hyperammonemic neonates: Role of early administration of metabolite scavengers and continuous hemodialysis.
    Abily-Donval L; Dupic L; Joffre C; Brassier A; Arnoux JB; Grimaud M; Lesage F; de Saint Blanquat L; Bekri S; Marret S; Pontoizeau C; Renolleau S; Ottolenghi C; de Lonlay P; Oualha M
    Arch Pediatr; 2020 Jul; 27(5):250-256. PubMed ID: 32418642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib-associated hyperammonemic encephalopathy successfully managed with higher intensity conventional hemodialysis: A case report.
    Haroon S; Ko S; Wong A; Tan PS; Lee E; Lau T
    Medicine (Baltimore); 2021 Feb; 100(5):e24313. PubMed ID: 33592876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism.
    Arbeiter AK; Kranz B; Wingen AM; Bonzel KE; Dohna-Schwake C; Hanssler L; Neudorf U; Hoyer PF; Büscher R
    Nephrol Dial Transplant; 2010 Apr; 25(4):1257-65. PubMed ID: 19934086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
    Dimopoulos MA; Roussou M; Gavriatopoulou M; Psimenou E; Eleutherakis-Papaiakovou E; Migkou M; Matsouka C; Mparmparousi D; Gika D; Kafantari E; Ziogas D; Fotiou D; Panagiotidis I; Terpos E; Kastritis E
    Am J Hematol; 2016 May; 91(5):499-502. PubMed ID: 26890495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal Ammonia Clearance for Hyperammonemia in Critically Ill Patients: A Scoping Review.
    Naorungroj T; Yanase F; Eastwood GM; Baldwin I; Bellomo R
    Blood Purif; 2021; 50(4-5):453-461. PubMed ID: 33279903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia after high-dose chemotherapy and stem cell transplantation.
    Frere P; Canivet JL; Gennigens C; Rebeix JP; Fillet G; Beguin Y
    Bone Marrow Transplant; 2000 Aug; 26(3):343-5. PubMed ID: 10967577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.